Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Shannon M Jones

Showing results (11-20 of 13) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 13 results.
American Journal of Physiology. Heart and Circulatory Physiology|September 15, 2018
Tefillin use induces remote ischemic preconditioning pathways in healthy menA Phillip Owens, Nathan Robbins, Keith Saum, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|March 31, 2018
PAR2 (Protease-Activated Receptor 2) Deficiency Attenuates Atherosclerosis in MiceShannon M Jones, Adrien Mann, Kelsey Conrad, et al.
JCI Insight|January 23, 2019
Human antigen R as a therapeutic target in pathological cardiac hypertrophyLisa C Green, Sarah R Anthony, Samuel Slone, et al.
Pageof 2

Showing results (11-20 of 13) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 13 results.
American Journal of Physiology. Heart and Circulatory Physiology|September 15, 2018
Tefillin use induces remote ischemic preconditioning pathways in healthy menA Phillip Owens, Nathan Robbins, Keith Saum, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|March 31, 2018
PAR2 (Protease-Activated Receptor 2) Deficiency Attenuates Atherosclerosis in MiceShannon M Jones, Adrien Mann, Kelsey Conrad, et al.
JCI Insight|January 23, 2019
Human antigen R as a therapeutic target in pathological cardiac hypertrophyLisa C Green, Sarah R Anthony, Samuel Slone, et al.
Pageof 2